Isotopia USA and E Solutions have finalized agreements to collaboratively design and construct their cutting-edge GMP manufacturing center. Isotopia aims to commence its US isotope manufacturing operations within the next 12 months, with a target of delivering GMP-grade products to its primary clientele by Q4 2024.
The facility will span 28,000 ft² and include essential features such as cleanrooms, analytical, and microbiological laboratories.
These facilities are vital for the high-volume production of Lutetium-177 n.c.a (177Lu) and Terbium-161 (161Tb) isotopes, critical components in advanced nuclear medicine applications.
